View in EDS

Phase II trial of fotemustine in patients with metastatic malignant melanoma.

Saved in:
Bibliographic Details
Title: Phase II trial of fotemustine in patients with metastatic malignant melanoma.
Authors: Falkson CI; Department of Medical Oncology, University of Pretoria, South Africa., Falkson G, Falkson HC
Source: Investigational new drugs [Invest New Drugs] 1994; Vol. 12 (3), pp. 251-4.
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print Cited Medium: Print ISSN: 0167-6997 (Print) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 7896545
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase II trial of fotemustine in patients with metastatic malignant melanoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Falkson+CI%22">Falkson CI</searchLink>; Department of Medical Oncology, University of Pretoria, South Africa.<br /><searchLink fieldCode="AU" term="%22Falkson+G%22">Falkson G</searchLink><br /><searchLink fieldCode="AU" term="%22Falkson+HC%22">Falkson HC</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228309330%22">Investigational new drugs</searchLink> [Invest New Drugs] 1994; Vol. 12 (3), pp. 251-4.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309330 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>0167-6997 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201676997%22">01676997 </searchLink><i>NLM ISO Abbreviation: </i>Invest New Drugs <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=7896545
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/BF00873967
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 251
    Titles:
      – TitleFull: Phase II trial of fotemustine in patients with metastatic malignant melanoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Falkson CI
      – PersonEntity:
          Name:
            NameFull: Falkson G
      – PersonEntity:
          Name:
            NameFull: Falkson HC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 1994
              Type: published
              Y: 1994
          Identifiers:
            – Type: issn-print
              Value: 0167-6997
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Investigational new drugs
              Type: main
ResultId 1